By Susan Tweit
One recent morning we sat in the VA Medical Center in Denver waiting for Richard’s oncology consult, followed, if all looked well with his blood work, by his third infusion of Avastin, a chemotherapy drug that aims to slow the growth of the aggressive glioblastoma colonizing his right brain.
After his oncologist beckoned us into her examination room, she asked how he is doing, and then looked at each of us in turn, waiting for our responses.